Article Text

Download PDFPDF
Management of therapeutic hypothermia for neonatal hypoxic ischaemic encephalopathy in a tertiary centre in South Africa
  1. Gugulabatembunamahlubi Tenjiwe Jabulile Kali1,2,
  2. Miriam Martinez-Biarge1,3,
  3. Jeanetta Van Zyl2,
  4. Johan Smith1,2,
  5. Mary Rutherford1,4
  1. 1Department of Paediatrics and Child Health, Stellenbosch University, Cape Town, South Africa
  2. 2Tygerberg Children's Hospital, Cape Town, South Africa
  3. 3Department of Paediatrics, Hammersmith Hospital, Imperial College, London, UK
  4. 4Department of Perinatal Imaging and Health, Division of Bioengineering and Imaging Sciences, Centre for Developing Brain, St Thomas’ Hospital King's College, London, UK
  1. Correspondence to Dr Gugulabatembunamahlubi Tenjiwe Jabulile Kali, Department of Paediatrics and Child Health, Faculty of Medicine and Health Sciences, Stellenbosch University, P.O. Box 19063, Tygerberg 7505, South Africa; kali{at}sun.ac.za

Abstract

Aim Therapeutic hypothermia (TH), shown in developed countries to improve outcome in infants with hypoxic-ischaemic encephalopathy (HIE), was introduced into standard care at Tygerberg Children's Hospital in 2008. We aimed to describe the management and characteristics of infants treated with TH at this tertiary centre as well as the logistical challenges encountered.

Methods Infants admitted for TH between 2008 and 2011 were included. They fulfilled TOBY study entry criteria and were cooled using a whole-body cooling system. A retrospective analysis of the cooling process and clinical findings was made using data collected during treatment.

Results 100 infants with mild (32%), moderate (45%) and severe (23%) HIE were treated over 3 years. Mean time to admission was 4.87 (±1.63) hours, median time from delivery to target temperature was 7.5 h (range 2.5–15.5 h). Mean temperature on admission was 35.5°C (±1.5°C). Overall, rectal temperature was within target temperature for 82.8% of the time. Complications noted were clinically suspected/proven infection (45%), abnormal coagulation tests (48%), thrombocytopenia (34%), need for inotropic support (17%), hypoglycaemia (4%) and hyperglycaemia (10%). Rate of follow-up at 1 year among survivors was 57%. Infants not attending 1-year follow-up were more likely to have HIV-infected mothers, but there were no other demographic or clinical differences when compared with those who attended follow-up.

Conclusions Cooling is feasible in a resource-limited setting, within a strict protocol. With close monitoring, the known and common complications occur as frequently as in less resource-limited settings. Surrogate markers of later outcome need to be explored where follow-up is problematic.

  • Neonatology
  • Monitoring
  • Temp Regulation

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.